Basal Cell carcinoma is the most common skin malignancy. It is a radiosensitive tumor. The main treatment modality includes radiotherapy and surgery. But topical antineoplastic agents have also found to be effective. In this article we report a case of basal cell carcinoma left temple, who was treated with topical 5-fluorouracil. Patient responded well to treatment and there was no residual malignant cells following treatment for 12 weeks. The relevant literature has been reviewed and the management has been discussed in brief.

Keywords: Basal cell carcinoma, Topical 5-Fluorouracil.

1. Devita, hellman, and Rosenberg’s Cancer principles and practice of Oncology, 10^th
2. Elliot Love, W & Bernhard, Jeffrey & Bordeaux, Jeremy. (2009). Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma. Archives of dermatology. 145. 1431-8. 10.1001/archdermatol.2009.291
3. Artis AH, Mosterd K, Essers BA et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal cell carcinoma: A single blind, non-inferiority, randomized controlled trial. Lancet Oncol 2013;14:647-654.

Dr Padmalakshmi Bharathi Mohan

Department of General Surgery

Government Mohan Kumaramangalam Medical college and Hospital, Salem